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ABSTRACT 
Sixty male golden Syrian hamsters (Lakeview Hamster Colony, 
Newfield, New Jersey), three months of age, were divided into five 
equal experimental groups and fed a standard laboratory diet. The 
animals of Group I (Control) received triweekly application of heavy 
mineral oil (USP) into the right buccal pouch with a No. 4 camel's 
hair brush for 16 weeks. The animals of Groups II, III, IV, and V 
received triweekly topical application of 7-12-dimethylbenzanthra-
cene (DMBA) at a concentration of 0.5% w/v in heavy mineral oil (USP), 
according to the technic of Salley (J. Dent. Res., 33:253-262, 1954). 
In this manner about 0.2 ml. of solution was deposited in the pouch 
at each painting, containing 1 mg. of DMBA. Animals in Group III, 
in addition to the application of DMBA, received a triweekly S.C. , 
injection into the groin of 2.5 mg. of cortisone acetate (Premo 
Pharmaceutical Laboratory, Inc., Hackensack, New Jersey). Group IV, 
prior to application of DMBA, received topical administration of 
0.025% Kenalog cream (Squibb & Sons, Co., New York). This was applied 
triweekly with one stroke of a No. 4 camel's hair brush. By this 
method, approximately 0.5 mg. of cortisone was applied to the pouch 
at each painting. The animals of Group V received I.M. injection 
into the pouch of 2.5 mg. of cortisone acetate in addition to appli-
cation of DMBA triweekly. All animals were examined at intervals of 
one week from the beginning of the experiment, and abnormal findings 
were registered. The buccal pouches of Group II presented with 100% 
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severe inflammatory response to the carcinogen about the end of the 
3rd week, while at this time, Groups III, IV, and V presented with 
50%, 25%, and 0% incidence of inflammation respectively. Later on 
in the 4th week, the inflammation in Group II developed into a mild 
ulceration in about 41% of the animals. In contrast to this obser-
vation, the animals in other groups did not exhibit any ulceration 
at this time. 
By the 5th week, the first neoplasm developed in Group II (DMBA 
alone), measuring 1 mm. in diameter. In about the 7th week, adhesion 
occurred in the buccal pouch, and a white, irregular, raised surface 
was noted in most animals, The latent period was varied from one group 
to another, being 8 weeks for Group II, 10 weeks for Group III, 9\ 
weeks for Group IV, and 12\ weeks for Group Vas determined by gross 
examination. At the end of the 16 weeks experimental period, all 
animals developed papillomatous tumors varying from 1 to 11 mm. in 
diameter. The tumors in Group II were greater in number and size than 
any other group. None of the tumors were as large as the largest tumor 
in this group. 
The weight gain of hamsters receiving triweekly topical cortisone 
and DMBA continued, when compared to those receiving systemic or local 
I.M. injection of cortisone. The highest mortality rate was observed 
in Group III and Group V (25%). 
Sixteen weeks after the start of the experiment, the animals were 
sacrificed, and autopsies were performed on all animals. Organs removed 
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for study were the buccal pouch, adrenal, kidney, liver, spleen, pan-
creas, and submandibular lymph node. The tissues were fixed in 10% 
fonnalin for 48 hours, sectioned in paraffin at a thickness of 6 u 
and stained wi ·h hematoxylin and eosin. 
Histological evaluation revealed a 91.66% carcinoma in Group II 
(DMBA alone), while only 55.6% and 66.6% carcinoma was developed in 
Group III (DMBA and systemic cortisone) and Group V (DMBA and local 
I .M. cortisone), respectively. Dyskeratosis was found in 66.6 % of 
Group III animals and in 100% of all other groups except Group I (min-
eral oil painting). 
Local injection of cortisone (Group V) appeared to be deleterious 
in terms of incidence of local infection, and those animals in this 
group that developed infection, also demonstrated carcinoma. Further-
more, those animals that did not develop infection during the experi-
mental period, although they developed tumors toward the end of the 
experiment, the tumors were free from malignancy. Group IV (topical 
cortisone and IlmA) did not show any significant difference in terms 
of malignancy when compared with Group II (DMBA alone). 
Microscopic evaluation of liver, pancreas, spleen, kidney, and 
submandibular lymph node revealed no histological changes, but marked 
evidence of adrenal atrophy was noted in Group III and Group V, which 
received systemic cortisone. 
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INTRODUCTION 
The causes of cancer are either chemical, physical (including 
radiation, and temperature changes), or biological, i.e., products 
formed by the host itself or by fungi, plants, and possibly other 
organisms. The distinction between a chemical cause of cancer and a 
biological cause is possibly arbitrary because a virus may be active 
by producing a chemical carcinogen if one considers that the nucleic 
acid of the virus is a chemical carcinogen. Some investigators (1,2) 
believe, however, that there is a clear difference between viral and 
chemical carcinogenesis. A virus does not create a new tumor, but 
constitutes a way of transmitting an existing tumor, as spores trans-
mit bacterial infections. Viruses and spores are carriers of genetic 
information. 
Of the causes of cancer in man, chemicals are the most important. 
Reasonable estimates are that not more than 5% of human cancer in man 
is due to viruses and less than 5% to radiation (3). Some 90% of can-
cer in man is therefore due to chemicals, but it is not known how much 
is due to endogenous carcinogens, and how much is due to environmertal 
factors. It should therefore be possible to prevent a great deal of 
human cancer by finding and removing chemical carcinogens from the en-
vironment. One hundred and fifty years after Pott's description of 
chimney sweep's cancer, 3,4-benzpyrene was isolated from coal tar, but 
it is probable that there are other unidentified carcinogens in soot 
•, 
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and coal tar. There is however, reasonable correlation between the 
experimental production of cancer in animals with coal tar and poly-
cyclic hydrocarbons and the incidence of skin cancer in people ex-
posed to tar, soot, oil and similar products. This correlation is 
easily seen because these materials generally produce cancer at the 
site of application. Kipling and Waterhouse (4) gave some epidemio-
logical evidence which indicated that cadmium compounds are a cause 
of prostatic cancer in man. Cadmium is used in industry in the man-
ufacture of pigments and in electroplating articles used in switches 
and switchgears. When administered to rats, cadmium compounds induce 
testicular tumors of the interstitial cells (5). This is an example 
of a frequently observed phenomenon of a carcinogen inducing tumors 
of different organs in different species. Cadmium resembles zinc in 
its chemistry, but biologically it is a zinc antagonist. The prostate 
gland has a high content of zinc and it is perhaps for this reason 
that the chronic toxic effect of cadmium is exerted on this organ in 
man (5). 
Fundamental research into carcinogenesis and therapy of cancer 
are linked because some of the agents used in the treatment of cancer 
are themselves carcinogenic. This has been recognized with radiother-
apy, but it also applies to chemotherapy. Therefore, estrogen, used 
for treatment of cancer of the breast in women and of cancer of the 
prostate in men, may induce cancer of several different organs in an-
imals. There is not, however, convincing evidence that estrogen in-
duces cancer in human subjects. Although nitrogen mustard and other 
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alkylating agents have been shown to be carcinogenic when injected in 
animals, there is no evidence that the therapeutic use of alkylating 
agents has produced cancer in patients (6). 
The similarity between experimental induction of cancer in ani-
mals and effects of the products in man is sufficiently close to make 
it prudent to test as many environmental factors as possible for car-
cinogenic or anti-carcinogenic activity. 
lS 
REVIEW OF LITERATURE AND OBJECTIVE 
Cortisone was first isolated from beef adrenal glands in 1935. 
In 1946, its synthesis was accomplished by using the bile acid deoxy-
cholic acid as starting point. In 1949, Kendall and Hench (7) report-
ed that cortisone gave remarkable relief in rheumatoid arthritis and 
subsequently its effectiveness in a wide variety of conditions has 
been reported. 
Cortisone is a potent hormonal substance with definite physiolo-
gic effects. With high or prolonged dosage and in some cases with the 
usual therapeutic dosage, ·pronounced hormonal effects occur. However, 
as with other adrenocortical hormones, such effect may be reversible 
and even dissappear after administration is discontinued (8). It af-
fects protein and carbohydrate metabolism, therefore promoting gluco-
neogenesis, hyperglycemia, glycosuria, and negative nitrogen balance. 
It inhibits the activity of the lymphatic system. 
The negative nitrogen balance induced by high-dosage cortisone 
therapy may delay bone and wound healing. Furthermore, it tends to 
suppress allergic inflammatory response. This reduces the formation 
of new blood channels and thus decreases blood flow which could car-
ry more inmune bodies and macrophages. Finally it is possible that 
it reduces serum g&Dllla globulin (9). 
The hormone does not affect infectious agents, but it decreases 
the inhibitors to infection. In the event that infection occurs dur-
ing cortisone treatment, specific antibiotic therapy without discon-
, . 
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tinuation of cortisone is suggested (10). 
Prolonged administration of large doses of cortisone in man and 
in animals causes a reduction in the size of the adrenal cortex. In 
man, adrenocortical insufficiency develops for varying lengths of time 
after termination of treatment (11). 
The first observation on chemical carcinogenesis was that of Sir 
Percival Pott in 1775, who noticed the cancer of the skin was espec-
ially common in men who worked with tar, and he suggested the tar 
acted in some manner as a causal agent. In 1915, Yamagiura (12) in 
his study, tested this agent by painting tar on rabbit's ear every 
day for six months, and succeeded in producing cancer of the skin. 
This was one of the most significant discoveries in the field of car-
cinogenesis, because for the first time it was possible to produce a 
malignant tumor at will. In 1932, Kennaway and Cook determined the 
active agent in tar was benzpyrene (13) and showed that it possessed 
a high degree of carcinogenic activity. Many other members of this 
group of polycyclic aromatic hydrocarbons with a benzene or aromatic 
six-membered ring structure proved to be carcinogenic. The carcin-
ogenic hydrocarbons must possess at least three condensed carbon rings 
to be active, and most of them have four (14). A very slight change 
in the chemical structure of a substance may convert it from a non-
carcinogenic into a carcinogenic agent. Methylcholanthrene is an 
active carcinogenic hydrocarbon prepared from cholic acid, an organic 
substance occurring naturally in the body, thus suggesting the pos-
sibility of an endogenous chemical carcinogen {14). 
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One of the earliest uses of methylcholanthrene in oral carcino-
genesis was by Levy (15), who in 1948 reported that painting of lab-
ial mucosa of mice and hamsters for a period of sixteen weeks, pro-
duced no gross or histological change in the treated tissue. In other 
experiments, , he utilized pellets of methylcholanthrene at the apex 
o: the lower central incisors in these animals and produced a dis-
orderly growth of enamel, dentin, and cementum. In 1950, Levy (16) 
in his later investigations succeeded in inducing malignant tumors 
of epithelial tissue and sarcoma by implanting 9,10-dimethyl-1,2-
benzanthracene in hamsters sublingual tissue. In this report, 80"/o 
of the hamsters exhibited tumor after sixteen to twenty weeks of 
experimental period. 
Levy, Gorlin, and Gottsegen (17) studied the effect of a single 
topical application of 9,10-dimethyl-l,2-benzanthrene on the skin ani 
mucous membrane of the lips in mice. The study was terminated after 
35 days with some premalignant changes noted histologically in the 
mucous membrane. 
Salley (18) has successfully induced malignant epithelial tumors 
in cheek pouch of the golden hamster by painting the pouches with 
three different hydrocarbon carcinogens: (1) 9,10-dimethyl-l,2-benz-
anthracene; (2) 20-Methylcholanthrene; (3) 3,4-benzpyrene. These 
carcinogens were dissolved in each of the two solvents, acetone and 
benzene. The animals were painted three times a week for 16 weeks. 
His results indicated that 9,10-dimethyl-l,2-benzanthracene in acetone 
was the most satisfactory of the three carcinogens in inducing malig-
18 
nant tumors. 
Kalas (19) was unsuccessful in his attempt to produce carcino-
matous changes by placing three grains of methylcholanthrene in ham-
ster cheek pouches prior to tying off the pouch orifice with wire 
ligature. 
Morris (20) studied the effect of various concentrations of 9,10-
dimethyl-l,2-benzanthracene. He utilized sixty 5 week old hamsters 
of both sexes and divided them into four littermated groups. Each 
group received one of the following concentrations of DMBA: 1.5%, 0.5 %, 
0.1%, and 0.05%. The carcinogen was applied 3 times a week to the 
medial wall of both pouches. After 15 weeks of experimentation, only 
3 animals in the 0.1% group had developed lesions and the animals of 
0.05% group were free from any gross changes, while the 0.5% concen-
tration group produced maximal number of tumors with minimal latent 
period. In a later study (21), he found no appreciable variation in 
time for the initial lesion to appear or in time for malignancy to 
develop with difference in age. Kreshover (22) has only demonstrated 
edema after 8 months of application with tobacco, but epidermoid car-
cinoma after 4 months of benzpyrene painting. Salley (23) has obser-
ved that one application of 0.5% 9,10-dimethyl-l,2-benzanthracene in 
mineral oil produced an inflananatory response, and that 3 paintings 
of hamsters cheek pouch caused degeneration and necrosis with some 
sloughing (Table 1). 
Salley (24) in 1958, painted palatal mucosa, cheek pouch, and 
ears of 19 hamsters with 9,10-dimethyl-l,2-benzanthracene and 3,4-
19 
benzpyrene, respectively. Ten of the nineteen (54%) of the animals 
showed evidence of early squamous cell carcinoma of the palate, while 
all of the animals presented with carcinoma in the pouch and on the 
ear. Hamsters treated with benzpyrene presented 16% incidence of pal-
atal malignancy, 94% in the cheek pouch, and 100% on the ears. Latent 
periods were 16, 6, and 14 weeks, respectively for the palate, pouches 
and ears of the 9,10-dimethyl-1,2-benzanthracene group, and 46, 25, 
and 32 weeks, respectively, for these anatomic sites with benzpyrene 
(Table 1), 
In 1959, Rowe and Gorlin (25) reported a study in which vitamin 
A deficiency seemed to accelerate tumor formation in the cheek pouch 
of the hamster. In addition, a higher tumor formation incidence in 
the group fed ad libitum than in the calorie-restricted group was in 
agreement with the findings of Tannenbaum (26) that tumor production 
is inhibited by restriction of caloric intake. 
Renstrup (27), conducted a study of the chronic mechanical irri-
tation on chemically induced carcinoma in the cheek pouch of 144 gold-
en Syrian hamsters. The carcinogen was a 0.5% concentration of 9,10-
dimethyl-1,2-benzanthracene. It was applied topically three times per 
week in the area of the median wall of the cheek pouch. A 0.01 inch 
stainless steel wire ligated around the mandibular first molar and 
projecting into the cheek pouch, served as chronic irritant for half 
of the group. The other group received carcinogen alone. It was noted 
that carcinoma occurred in four weeks when the application of local 
irritation was combined with that of carcinogen, whereas 10 weeks were 
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required before carcinoma was induced by carcinogen alone (Table 1). 
The carcinogenic substance used for experimental purposes have 
hitherto been non-water soluble hydrocarbons. A 0.25% solution of 4-
nitroquinaline N-oxide in propylene glycol was used by Fujino (28). 
When this water soluble compound was applied by repeated painting of 
the mucosa of the lower lip in 250 mice, it gave rise to carcinoma in 
47%, whereas application of 4-nitroquinaline N-oxide, when accompan-
ied by mechanical injury to the lower lip with metal wire, gave rise 
to oral carcinoma of the same pattern in 77% of animals (28) (Table 1). 
One of the recent investigations was done by Hamner (29) in re-
gard to response of hamster's cheek pouch autografts to 9,10-dimethyl-
l,2-benzanthracene paintings. Twelve male and eleven female golden 
hamsters were employed. Circular autografts, approximately 2 to 2.5 
cm. in diameter, were cut from surgical specimens of the excised pouch 
and placed in appropriately sized, excised beds of the submucosal 
layer of the dorsal skin of the same animal. These autoplants were 
sutured securely into place with interrupt~d silk sutures. After 10 
days, the surrounding dorsal skin was painted three times per week for 
15 weeks with an 0.5% solution of 9,10-dimethyl-l,2-benzanthracene. 
Three male and three female hamsters were used as normal control. Their 
dorsal skin was clipped, and a 4 cm. area was painted with an 0.5 per-
cent solution of 9,10-dimethyl-l,2-benzanthracene for a similar length 
of time. After 15 weeks, carcinomas were induced in dorsal skin in 
100% of hamsters and only 5% of the autografts. The low percentage of 
tumors induced in the buccal pouch in its altered anatomic position 
21 
is a finding which is in marked contrast to the pouch's high response 
to 9,10-dimethyl-l,2-benzanthracene induced oncogenesis in its natural 
location (18,24) (Table 1). 
The relatinn~hip of corticosteroid hormone and carcinogenesis has 
receiwed much attention in recent years. The initial work in this area 
was done by Sugiura (30) who described the influence of aqueous extract 
of suprarenal cortex on the growth of carcinoma, sarcoma, and a vari-
ety of melanomas in animals. In this study, he found no appreciable 
effect of aqueous extract on developing tumors. Subsequently, a var-
iety of experiments have been reported, and the site studied most com-
prehensively has been the mouse skin. Sulzberger (31) and co-workers 
found that after six weeks of methylcholanthrene application to the 
~kin of mice, papillomas developed in 69% of the animals in : e : ted 
daily with 0.5 mg. of cortisone, and in 48% of untreated anima Js. A 
retardation in carcinogenesis has been reported by Ghadially and Green 
(32). They utilized 0.2% solution of 9,10-dimethyl-l,2-ben~anthracene 
and two drops of cortisone suspension containing 12.5 mg./ml. on the 
skin of a group of mice for 16 weeks . Gillman (33), on the other hand, 
used 0.3% methylcholanthrene and 0.2 mg. of cortisone acetate, also 
on the skin, for 33 weeks, and reports no appreciable effect of cor-
tisone on the development of squamous cell carcinoma (Table 1). 
Spain (34), in an attempt to gain further information about the 
role of cortisone re~ati.ve to experimental tumor production, and metas-
tasis, used 100 mice ·,) 6-8 weeks old, divided into various experimental 
groups. The agents used were 3-methylch<>lanthrene 0.6% w/v in benzene, 
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and a 2 mg. I.M. daily cortisone acetate. His data demonstrated that 
the enhancement of tumor formation by cortisone occurs even if hor-
mone is only administered in the early phases of the carcinogenesis 
(Table 1). 
Engelbreth-Holm (35) in his investigation, administered .2 mg. 
of cortisone intraperitoneally, and 0.5% topical solution of 9,10-
dimethyl-l,2-benzanthracene, for 8 weeks to 35 female mice. His 
results demonstrate that cortisone reduces the number, and delays the 
development of epidermal tumors. 
Various experimental technics have been used previously to dev-
elop carcinoma in laboratory animals. The dosage of cortisone has 
ranged from 0.2 mg. daily in Engelbreth-Holm's (35) study to 2 mg. 
daily in Spain's (34) study of mice. The various routes of cortisone 
administration have included subcutaneous, intraperitoneal, and intra-
muscular, as well as local injection. 
Sabes (36) reports local injection of 0.05 cc of 0.025% corti-
sone has been found to inhibit the development of chemically induced 
neoplasm of hamster submandibular glands. On the other hand, Anbari 
(37) suggested that 0.5 mg. systemic administration of cortisone en-
hances the process of chemical carcinogenesis in rat salivary glands 
so that carcinomas develop more rapidly in the submandibular gland 
after implantation of pellets of dimethylbenzanthracene. 
Silberman (38) has shown that chemical carcinogenesis of hamster 
buccal pouch is augmented by the local application of croton oil to-
gether with the carcinogenic chemical agent. Sabes (36) reports that 
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the effect of locally applied cortisone prior to application of car-
cinogen inhibits the development of chemically induced neoplasms; how-
ever, systemic administration of cortisone appears to enhance the pro-
cess of chemical carcinogenesis. 
Shklar (39) utilized 90 male hamsters and divided them into 6 
equal experimental groups of 15 animals each. Two groups served as 
control for 8 and 16 week experimental periods. In the remaining 4 
groups, the right buccal pouch was painted three times weekly with 9, 
10-dimethyl-l,2-benzanthracene and sacrificed at 8 and 16 weeks. One 
8 and one 16 week experimental group were also injected three times 
weekly with 2. ·0 mg. of cortisone acetate. It was found that in those 
animals receiving cortisone as well as 9,10-dimethyl-l,2-benzanthra-
cene applications, the development of initial buccal carcinomas was 
hastened (Table 1). 
Siegel (40) reports that administration of a combination of DMBA, 
cortisone, and dimethyl sulfoxide, prevents carcinoma in hamster's buc-
cal pouch, and histologically, epithelial tissue was atrophic rather 
than hyperplastic. 
Since the role of cortisone in oral carcinogenesis depends on the 
route of application, dosage, and time of administration of steroid in 
relation to the application of carcinogen; and furthermore, tumor dep-
ression by cortisone (32) is related to the effect of this hormone on 
lysosomes and lysosomal enzymes in the initial stages of cell division 
and tumorinogenesis, it appears paradoxical to observe tumor promotion 
after treatment with cortisone in the hamster cheek pouch. 
., 
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In light of the enhancing effect of membrane stabilizer on DMBA 
carcinogenesis in some studies (31, 34, 37, 39), and contradictory re-
ports by other investigators (33, 35, 36, 40), this study is designed 
to investigate and evaluate the effect of topical application versus 
systemic application of membrane stabilized cortisone. We hope to as-
sess the clinical and histologic enhancing or inhibitory effect of this 
agent as determined by a single investigator. 
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MATERIAL AND METHODS 
Sixty male golden Syrian hamsters (Lakeview, Hamster Colony, New-
field, New Jersey) three months of age were used in this study. They 
were housed in groups of four in mesh wire cages, over bedding of "pel-
licel". Their diet consisted of laboratory chow and water given ad 
libitum. 
The animals were divided into five groups of 12 animals in each 
group. 
Group I. 
Group II. 
Group III. 
Group IV. 
Group V. 
Control, mineral oil painted, 16 week experimental 
period. 
DMBA painted, 16 week experimental period. 
DMBA painted, cortisone systemically injected, 16 
week experimental period. 
Topical cortisone, DMBA painted, 16 week experi-
mental period. 
DMBA painted, cortisone locally injected, 16 week 
experimental period. 
The technic of carcinogenesis was that of Salley's (18). The 
carcinogen used was 7-12-dimethylbenzanthracene (Distillation Products, 
Division of Eastman Kodak Company) at a concentration of 0.5% w/v in 
heavy mineral oil (USP). All solutions were prepared once a month and 
were stored in dark bottles at room temperature. DMBA solution was 
applied to the right buccal mucosa with one stroke, of Groups II, III, 
IV, and V with a No. 4 camel's hair brush tri-weekly. In this manner 
about 0.2 ml. of the solution was deposited in the pouch at each paint-
ing, containing 1 mg. of DMBA. Animals in Group III, in addition to 
.. , 
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the application of DMBA, received a S.C. injection into the groin of 
2.5 mg. of cortisone acetate (Premo Pharmaceutical Laboratory, Inc., 
Hackensack, New Jersey). The cortisone was administered three times 
a week during the course of the experiment. 
The animals of Group IV prior to application of DMBA received 
topical application of 0.025% Kenalog Cream (Squibb & Sons, Co., New 
York, New York), with one stroke of a No. 4 camel's hair brush tri-
weekly. By this method, approximately 0.5 mg. of cortisone was app-
lied to the pouch at each painting. The animals of Group V received 
I .M. injection into the pouch of 2 .• 5 mg. of cortisone acetate in ad-
dition to application of DMBA tri-weekly. 
At the conclusion of the experimental period, the animals were 
sacrificed, the right buccal pouches were removed and fixed in 10% 
formalin. Autopsies were performed on all animals. Organs removed 
for study were the adrenal, liver, kidney, spleen, pancreas, and sub-
mandibular lymph node. 
The tissues were embedded in paraffin, cut at a thickness of 6u 
and stained routinely with hematoxylin and eosin. 
To clinically standardize the assessment of tumor development, 
exophytic buccal mucosa lesions up to 1 am. in diameter were classi-
fied as nodules. Lesions from 2-4 mm. in diameter were called Grade 
I papillomas. Moreover, lesions from 5-7 nun. classified as Grade II 
papilloma, and Grade III papilloma was from 8-11 mm. 
Histological classification and description was made on the bas-
is of hyperkeratosis, parakeratosis, carcinoma in-situ, and epidermoid 
carcinoma with Grading system from I-IV. 
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RESULTS 
GROSS OBSERVATIONS OF ALL GROUPS-The animals were examined at 
intervals of one week from the beginning of the experiment, and ab-
normal findings were registered. The latent period for tumor pro-
duction was measured as the time required after the initial applica-
tion of the carcinogen, for appearance of the first grossly observ-
able tumor. The initial gross alteration of the hamster cheek pouch 
mucosa, indicating that a tumor would subsequently occupy a given 
site was observed to take one of the three forms. It was first seen 
as a tiny, peduncular, reddish papilloma; a small, distinct, rounded, 
raised, pink area; or an irregular whitish or hyperkeratotic area. 
The type of change first observed and its location were recorded. 
The area of alteration was examined at each painting period, and any 
changes were recorded weekly. 
The weight gain of hamsters receiving triweekly topical cortisone 
and DMBA continued, when compared to those receiving systemic or local 
I.M. injection of cortisone. This fact is reflected in the signifi-
cant differences of mean final body weights (Table 2). Hamsters of 
Group V (DMBA and local I.M. cortisone) had the lowest mean final body 
weight (103.2 gm.) and the highest mortality rate (25%). In addition 
to this, towards the 5th week, hamsters in Groups III and V developed 
dryness and scaliness of the skin with varying degrees of alepecia 
(Fig. 1). By comparison, Groups II and IV retained a clear and normal 
coat; however, multiple papillary skin lesions developed on the right 
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corner of the mouth in Groups II, III, IV, and V, which disappeared 
gradually later on in the 9th week. Pouches of Group V (I.M. local 
cortisone) displayed the slightest degree of erythema, but frequent-
ly demonstrated localized infection (Fig. 2). Papilloma incidence 
was associated with erythema, and all were preceded with varying de-
gree of ulceration in all groups of animals. Buccal pouches of Group 
II presented an initial severe inflammatory response about the 3rd 
week of the experiment (Fig. 3). Later on in the 4th week, the in-
flammation developed into a mild ulceration in about 41% of the an-
imals in this group (Table 3). In contrast to this observation, the 
animals in other groups did not exhibit any ulceration at this time 
(Table 3). The inflammatory response receded to some degree as the 
experiment progressed, and pouches became. somewhat firmer and less 
resilient. In most animals in this group, the pouches never complete-
ly healed. By the 5th week, the first neoplasm developed in Group II, 
measuring l mm. in diameter (Fig. 4). As more and more tumors devel-
oped, the body of the papillomas expanded considerably, but remained 
constricted at the base. In about the 7th week, adhesion occurred 
and a white irregular, raised surface was noted in most animals. The 
pouch depth was reduced from a normal 3-3.5 cm. to 2-2.5 cm. (Fig. 5 
& 6). At the end of the 9th week after the initial painting, tumors 
were present in 83.3% of animals in the group painted with DMBA alone, 
while only 40% of the animals in Group III developed tumors at this 
time (Table 3). 
The latent period (time for one half of a group to evidence tu-
30 
mor formation) was varied from one group to another, being 8 weeks 
for Group II, 10 weeks for Group III, 9\ weeks for Group IV, and 12\ 
weeks for Group Vas determined by gross examination (Table 3). 
Toward the end of the 16 week experimental period, all groups 
except for the control, presented some degree of swelling of the 
right buccal pouches, adjacent mucous membrane, and developed papil-
lomatous tumors, varying from 1 to 11 nun, in diameter (Fig. 7, 8, 9, 
& 10). The tumor-like masses appeared pink, granular, and moderately 
hemorrhagic. The tumors in Group II were greater in number and size 
than any other group of animals in this experiment (Table 4). At the 
termination of the study, none of the tumors were as large as the lar-
gest tumor in this group. 
The average number of tumors presented per animal, clinically, 
at the time of sacrifice, was 0, 5.66, 4.68, 5.0, and 3.55 for Groups 
I, II, III, IV, and V respectively (Table 5). 
In as much as right paraoral skin lesions were present with the 
same predilection as intraoral lesions in each group, it is assumed 
that paraoral lesions resulted from dripping from pouches to the skin 
surface. 
Hamsters dying before termination of study, apparently died from 
dehydration subsequent to "wet tail", or toxicity to cortisone, and 
not as a result of the infection or tumor. 
Autopsies revealed no gross changes in liver, pancreas, kidney, 
and lymph node, but marked evidence of adrenal atrophy was noted in 
Groups III and V which received systemic cortisone (Fig. 11). 
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MICROSCOPIC OBSERVATIONS-Microscopic examination of the right 
buccal pouches revealed the following characteristics in the experi-
mental groups: 
Group I: The right buccal pouches of Group I were normal and were 
characterized by cornified squamous epithelium and striated muscle. 
The epithelium presented with a well developed stratum cornium, stra-
tum granulosum, and stratum spinosum, and regularly oriented stratum 
germinatum. The lamina propria was composed of fibrous connective tis-
sue and bordered by longitudinal skeletal muscle fibers, with no evi-
dence of acute or chronic inflammation (Fig. 12). 
Group II: This group revealed frank squamous cell carcinoma with 
nests and sheets of atypical epithelial cells invading the submucosal 
connective tissue (Fig. 13). A higher magnification of these tumors 
are shown in Fig. 14. Here can be seen hyperchromatic, prominent nu-
clei, and some abnormal mitotic figures. Also exhibited in this group 
were ulceration and necrosis with heavy inflanmatory infiltrate. 
Group III: The right buccal pouches of this group presented with 
several foci of well differentiated epidermoid carcinoma and moderate 
inflannatory infiltrate (Fig. 15). Forty-four percent of the animals 
in this group presented with moderate to severe acanthosis and carcin-
oma in-situ (Fig. 16), but only 55.6% epidermoid carcinoma (Table 5). 
Group IV: The infl811'1Ilatory response in this group was less pro-
nounced than in Group II, but when compared to Group III, they dem-
onstrated a greater degree of inflammation. The right buccal pouch 
of this group showed numerous areas of dysplasia and development of 
• 
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epidermoid carcinomas. These tumors generally appeared as papillary 
lesions with numerous areas of keratin pearl formation (Fig. 17). In-
vasion of underlying connective tissue could be observed, and cellular 
pleomorphism of the epithelium was prominent. In numerous areas loc-
alized foci of early malignant neoplasia could be observed with down-
ward extension and proliferation of abnormal epithelial cells (Fig. 
18). The cells presented an altered nuclear cytoplasmic ratio, hyp-
erchromaticity, pleomorphism, and loss of polarity. 
Group V: The right buccal pouch of animals painted with DMBA am 
treated with local injection of cortisone, presented some atrophic al-
teration and degeneration of some underlying connective tissue. The 
presence of granulation tissue and occasional macrophage was notable. 
lnflaanatory infiltration was also observed in deeper subepithelial 
layers. Five out of six animals presented with a great deal of gran-
ulation tissue, and also epidermoid carcinoma of Grade II variety 
(Fig. 19). In three animals or 33.3%, there were areas of dysplasia, 
but no epidermoid carcinomas (Fig. 20) & (Table 6). 
The detailed histological results of each group was recorded on 
the basis of degree of hyperkeratosis, acanthosis, parakeratosis, par-
abasilar hyperplasia, dyskeratosis, carcinoma in-situ, carcinoma with 
Grading from I-IV, and inflammation. Malignant tumors were noted to 
occur in one of three ways: (1) solid exophytic lesions; (2) endophy-
tic growth; (3) intraepithelial carcinoma. Table 6 illustrates the 
incidence of histologic changes in various groups according to the 
pre-established categories. There was no difference in incidence of 
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malignant tumors between animals of Group II and IV. 
In Group II, 91.66% of the right pouches exhibited carcinoma, 
while only 55.5% and 66.6% carcinoma developed in Group III and V re-
spectively (Table 5). Hence, animals treated with carcinogen (DMBA) 
and that received systemic administration of cortisone acetate, dis-
played less anaplastic tendency than animals treated with the carcin-
ogen alone. Dyskeratosis was found in 66.6% of Group III and in 100"/o 
of Groups II, IV, and V (Table 6). Judging by the effects of the tri-
weekly intramuscular injection of systemic cortisone as compared to 
the effects of local injection of cortisone, it appears that the local 
injection not only is deleterious in terms of incidence of local in-
fection, but also it increases the severity of the malignant transfor-
mation. In all probability this difference is due to the trauma of 
needle puncture with creation of a port of entry for the carcinogen. 
Several benign tumors were noted in Group V animals, but those 
animals that presented with definite malignant tumors also showed pro-
nounced granulation tissue histologically. 
The incidence of necrosis and degeneration of connective tissue 
was lowest in Group IV receiving topical cortisone, and highest in 
Group II receiving DMBA alone. On the other hand, both groups devel-
oped the same number of malignant tumors at the termination of the 
experiment. 
Microscopic studies of liver, pancreas, kidney, and spleen, re-
vealed no histological changes. Submandibular lymph node sections, 
however, revealed occasional non-specific hyperplasia. There was no 
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evidence of metastasis in any of these organs (Fig. 21-25). 
The size of the adrenal gland in Groups III and V was diminished 
considerably when compared to the adrenal gland of Group I (Fig. 26 & 
2-7). After 16 weeks of cortisone therapy, representative sections of 
adrenal gland tissue from all groups, indicated a notable de.crease in 
adrenal size in Groups III and V. As expected, there was no change 
in the Group II adrenal gland. Furthermore, Group IV, which received 
topical application of cortisone for the same period of time, also 
demonstrated no change in the adrenal gland. 
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DISCUSSION 
The result of the experiment in Group III suggests that cortisone 
applied systemically suppresses to some degree development of carcin-
oma by a powerful carcinogen. This effect is probably produced by the 
known epidermal mitotic depressant action of cortisone. Earlier find-
ings of Ghadially and Green (32)° showed that after four applications 
of DMBA over 14 days, the epidermal cells of the mouse ear became rel-
atively refractory to the antimitotic action of cortisone given sys-
temically. It is therefore expected that chemical carcinogenesis 
would not be delayed or prevented by cortisone, whereas, in fact, the 
present results show that it was. A possible explanation for this 
could be that onset of appearance of resistance to cortisone depends 
directly on the rate of mitosis. In the event that this rate is dim-
inished by a very high dose of cortisone from the onset of carcinogen-
esis, tumor development appeared much slower with less incidence of 
malignancy. 
Shklar (39) reported an enhancing effect on DMBA induced hamster 
cheek pouch carcinogenesis. In this study, 2 mg. of cortisone acetate 
were injected subcutaneously three times weekly for eight or sixteen 
weeks during DMBA application. This increase in tumor production was 
attributed to the antianabolic action of cortisone which may have fac-
ilitated invasive growth, or to suppression of antibody formation by 
cortisone. In the present study, tumor inhibition may be attributed 
to the use of larger doses of corticosteroid, which seems to be in 
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qreement with the earlier study of the effect of systemic cortisone 
on submandibular salivary gland by Sabes (36). 
In Group IV of this experiment we found no suppression of buccal 
pouch carcinogenesis by cortisone, but on the other hand we found no 
promotion of tumor formation as reported by other investigators (31, 
34). 
Boutwell (41) reports that the DMBA-induced hamster cheek pouch 
carcinogenesis was enhanced when cortisone was applied topically 3 
minutes prior to application of the carcinogen. However, the reverse 
procedure did not result in any significant changes as compared with 
controls. ln this investigation, 0.0S ml. of a 0.02% solution of cor-
tisane acetate in saline was applied twice weekly. In the present 
study, we used 0.025% Kenalog ointment in polyethylene and mineral gel 
base (Squibb), one half times the amount used in previous study. The 
divergence of the results is probably related to the above differences 
in the dose, type of vehicle, and the time of cortisone administration. 
In addition, in the present study, the major production of the tumor 
growth was noted after the ninth week, whereas the duration of the ex-
periment cited (41) was less than ten weeks. Furthermore, we found 
the delay in latent period and decrease in overall tumor dimension to 
be in agreement with Ghadially's (32) study on skin ~ cinogenesis. 
Local injections of cortisone in this investigation resulted in 
suppression of epidermoid carcinoma in those animals that did not de-
velop infection. On the other hand, animals that developed infection 
at the site of chronic needle puncture, developed more infiltrating 
• 
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carcinoma. According to Salaman (42) no known agent is a pure initia-
tor or a pure promotor, and the definitions of these are interdepend-
ent. For the purpose of this investigation, the term cocarcinogen im-
plies an agent that may by itself produce tumors, or act additively 
with another agent producing tumors in greater number, or faster than 
if the second agent were used alone. A promoting agent, or factor, 
then can be defined as an agent that by itself produces no tumors, but 
when accompanied with a carcinogen produces faster and/or greater num-
ber than when carcinogen is applied alone. Therefore, repeated local 
intramuscular administration of cortisone in the presence of infection 
is classified as an enhancing factor. This appears to offer some evi-
dence that trauma may act independently or in conjunction with carcin-
ogen in producing carcinoma. 
Renstrup's (27) study of the effect of chronic mechanical irrita-
tion on chemically induced carcinoma, proved to have an enhancing ef-
fect on the process of tumorinogenesis, but chronic mechanical irri-
tation alone could not produce carcinoma. The break in epithelial 
tissue as the result of the needle puncture may be an important factor. 
Simpson (43) suggested that carcinogens penetrate more readily when a 
portal of entry is provided either by natural structures, such as hair 
follicles, or sebaceous glands, or when ulceration creates a break in 
the epithelial surface. Penetration of the carcinogen into deeper lay-
ers of the epithelium may have caused the more invasive carcinoma. It 
is further postulated that the proliferating epithelium at the site of 
injections is more susceptible to the action of the carcinogen. The 
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effect of the inflanmatory exudate, bacteria, and products of tissue 
destruction on the epithelium adjacent to the site of injection and 
on the carcinogen itself, also must be considered. In this experi-
ment only animals that developed infection during the course of the 
treatment developed invasive carcinoma and a great deal of granulation 
tissue and necrosis. 
The carcinomas that developed in Group Vin the remainder of the 
cheek pouches were exophytic. The degree of invasion may have re-
sulted because of the effect of the carcinogen on the deeper layers 
of epithelial cells adjacent to needle punctures and subsequent ulcer-
ations. 
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Table 1: Chronology (1931-1970) of Some Major Findings Related to Experimental Carcinogenesis 
NO. OF CARCINOGEN PERCENT 
AN~ AND OtHEfl AMOUNT & DURATION ANIMALS SITE OF 
USED IN TREATMENT ROUTE OF IN DEVELOPING PRIMARY 
AUTHOR YEAR EXPERIMENT USED . - ADMINISTRATION WEEKS TUMORS TUMOR 
Sugiura 1931 Transplant- 2 cc cortical 8 100 Various 
ed sarcoma extracts 
Engelbreth- 1953 35 Mice 9,10-DMBA .5% topical 8 90 Dorsal skin 
Holm 1953 35 Mice 9,10-DMBA+ .5% topical 8 50 Dorsal skin 
cortisone .2 mg I.P. 
Sulzberger 1953 65 Mice MCh in .6% w/v, topical 6 69 Skin 
Benzene+ 
cortiscne .5 mg I.M. 
1953 47 Mice MCh+ .6% w/v 6 48 Skin 
saline .25 cc 
1953 65 Mice MCh in .3%, topical 6 24 Skin 
carbowax+ 
cortisone .5 mg I.M. 
1953 47 Mice MCh+ .3%, topical 6 9 Skin 
saline • 25 cc I.M. 
Ghadially& 1954 15 Mice 9,10-DMBA in .2%, 2 drops 12 0 Skin 
Green paraffin+ 
cortisone 2 drops(l2.5mg/ml) +7da. prior 
1954 15 Mice 9,10-DMBA+ .2%, 2 drops 100 Skin 
saline 2 drops +7 da. 
1954 15 Mice 9,10-DMBA+ 3%, 2 drops 13 10 Skin 
cortisone 2 drops(12.5mg/ml) +1 da. ~ w 
~ 
Table 1: (Cont'd) 
1954 15 Mice 9,10-DMBA+ 3%,2 drops prior 100 Skin 
saline 2 drops 
1954 15 Mice 9,10-IMBA 3% 13 90 Skin 
Salley 1954 6 Hamsters 9,10-DMBA in • 5% sol. 16 100 Buccal Pouch 
acetone topical 
Salley 1954 6 Hamsters 9,10-DMBA in • 5% sol. 16 75 Buccal Pouch 
benzene topical 
Salley 1954 6 Hamsters 20-MCh in • 5% sol. 16 40 Buccal Pouch 
acetone topical 
Salley 1954 6 Hamsters 20-MCh in • 5% sol. 16 0 Buccal Pouch 
benzene topical 
Salley 1954 6 Hamsters 3,4-BP in • 5% sol. 16 40 Buccal Pouch 
acetone topical 
Salley 1954 6 Hamsters 3,4-BP in .5% sol. 16 0 Buccal Pouch 
benzene topical 
Gillman 1956 26 Albino MCh in ace- .3%,1 drop 33 100 Skin 
mice tone+ 
cortisone .2 mg(lOOmg in lee 
95% alcohol) 
Gillman 1956 26 Albino MCh + .3%,1 drop 33 100 Skin 
mice alcohol 
Gillman 1956 26 Albino MCh + .3%, 1 drop 33 100 Skin 
mice cortisone .25 mg subcutaneous 
Gillman 1956 26 Albino MCh + .3%, 1 drop 33 100 Skin 
mice saline .25 mg subcutaneous 
Spain 1956 30 Mice 3-MCh in .6% w/v, topical 40 47 Skin 
benzene 
Spain 1956 39 Mice 3-MCh + .6% w/v, topical 40 59 Skin 
cortisone 2mg 5da. prior & 
lOda. thereafter 
Spain 1956 32 Mice 3-MCh + .6% w/v, topical 40 74 Skin ~ ~ 
cortisone 2mg for 4 wks . 
Table l: (Cont'd) 
Levy 1958 18 Mice 9,10-DMBA .3 mg I.M. 64 83 Tongue 
' 
Salley 1958 19 Hamsters 9,10-DMBA .5% topical 32 100 Ear 
Salley 1958 19 Hamsters 9, 10-DMBA .5% topical 25 100 Cheek 
Salley 1958 19 Hamsters 9,10-DMBA .5% topical 46 52 Palate 
Salley 1958 19 Hamsters 3,4-BP .5% topical 14 100 Ear 
Salley 1958 19 Hamsters 3,4 _:BP .5% topical 6 94 Cheek 
Salley 1958 19 Hamsters 3,4-BP .5% topical 16 82 Palate 
Morris 1961 15 Hamsters 9,10-DMBA .5% in mineral 10 . 100 Buccal Pouch 
at 3 wks. oil 
Morris 1961 15 Hamsters 9,10-DMBA .5% in mineral 11 85 Buccal Pouch 
at 6 wks. oil 
Morris 1961 15 Hamsters 9,10-DMBA • 5% in mineral 11 75 Buccal Pouch 
. 
at 9 wks. oil 
Morris 1961 15 Hamsters 9,10-DMBA 1.5% in mineral 9 71 Buccal Pouch 
oil, topical 
Morrfs 1961 15 Hamsters 9,10-DMBA 0.5 % in mineral 12 94 Buccal Pouch 
oil, topical 
Morris 1961 15 Hamsters 9,10-DMBA 0.1% in mineral 19 64 Buccal Pouch 
oil, topical 
Morris 1961 15 Hamsters 9,10-DMBA 0.05 % in mineral 8 0 Buccal Pouch 
oil, topical 
Morris 1961 15 Hamsters 9,10-DMBA .5% in mineral 8 100 Buccal Pouch 
oil 3 times pr wk. ~ VI 
Table 1; (Cont'd) 
Morris 1961 15 Hamsters 9,10-DMBA • 5% in mineral 8 26 
Buccal Pouch 
oil, 2 times pr wk • 
Renstrup 1962 72 Hamsters 9,10-DMBA • 5% topical + 4 100 
Cheek 
Mech. Irritant 
Renstrup 1962 72 Hamsters 9,10-DMBA .5% topical 10 100 
Cheek 
Sabes 1963 12 Hamsters 7 ,12-DMBA .05cc in .5% 20 44.4 
Buccal Pouch 
liquid petrolatum 
Sabes 1963 12 Hamsters 7,12-DMBA+ .05cc in .5% 20 57.1 
Buccal Pouch 
liquid petrolatum 
cortisone .025% topical 
Sabes 1963 12 Hamsters Cortisone+ .025% topical 20 92.3 
Buccal Pouch 
7,12-DMBA .05cc in .5% 
liquid petrolatum 
Sabes 1963 18 Hamsters Cortisone .05cc of .025% 29 17.6 
Submandibular 
acetate+ injected in gland gland. 
7,12-DMBA • 5% injected in 
gland. 
Sabes 1963 18 Hamsters 7,12-DMBA + .05cc of .5% 29 40 
Submandibular 
saline .05cc gland. 
Sabes 1963 18 Hamsters 7, 12-DMBA 0 . 1 cc Of • 25% 29 40 
Submandibular 
gland. 
Silberman 1963 12 Hamsters 9,10-DMBA + .5% topical 8 40 
Buccal Pouch 
2-3 mo. old Croton oil 1% topical 
Silberman 1963 12 Hamsters 9,10-DMBA .5% topical 4 88 
Buccal Pouch 
2-3 mo. old 
Silberman 1963 12 Hamsters 9,10-DMBA .5% topical 8 40 
Buccal Pouch 
12-14 mo. Croton oil 1% topical 
Silberman 1963 12 Hamsters 9,10-DMBA .5% topical 10 25 
Buccal Pouch 
12-14 mo. 
~ 
CJ\ 
Table 1: (Cont'd) 
Fujino 1964 125 Mice 4-NQO .25% topical 34 47 Lover lip 
Fujino 1964 125 Mice 4-NQO .25% topical+ 79 77 Lower lip Mech. Irritant 
Anbari 1965 10 Albino DMBA pellets implanted 12 0 
Submaxillary 
rats. gland. 
Anbari 1965 10 Albino DMBA pellets+ implanted 12 60 
Submaxillary 
rats. cortisone . 5mg parenteral gland . 
Hamner 1966 23 Hamsters 9,10-DMBA .5% topical 15 100 
Dorsal skin 
Hamner 1966 23 Hamsters 9,10-DMBA .5% topical 15 5 
Autographed 
cheek to 
dorsal skin 
Shklar 1966 15 Hamsters 9,10-DMBA+ .5% topical+ 8 50 
Buccal Pouch 
cortisone 2mg I.M. 
Shklar 1966 15 Hamsters 9,10-DMBA .5% topical 8 15 
Buccal Pouch 
Shklar 1966 15 Hamsters 9,10-DMBA+ .5% topical 16 100 
Buccal Pouch 
cortisone 2mg I.M. 
Siegel 1969 10 Hamsters 9,10-DMBA+ .5%(mineral oil) 10 0 Buccal Pouch 
DMSo+ 7ff/o topical 
triamcinolone .025% topical 
Siegel 1969 10 Hamsters 9,10-DMBA+ .5% topical 10 10 
Buccal Pouch 
Triamcinolone .025% topical 
Siegel 1969 10 Hamsters 9,10-DMBA .5% topical 10 10 
Buccal Pouch 
Siegel 1969 10 Hamsters DMSO + 7(1'!. topical 10 40 
Buccal Pouch 
triamcinolone .025% topical 
-&:--
..., 
Table 1: (Cont'd) 
Polliack 
Polliack 
1970 
1970 
6 Hamsters 
6 Hamsters 
9,10-DMBA 
9,10-DMBA + 
cortisone 
.5% topical 
.5% topical 
.05% topical 
12 
12 
83 
33.3 
Buccal Pouch 
Buccal Pouch 
LEGEND: DMBA= Dimethylbenzanthracene, BP= Benzpyrene, NQO= Nitroquinaline Oxide, DMSO= Dimethyl 
Sulfoxide, MCh= Methylcholanthrene. 
+:--
(X) 
TABLE 2: BAS IC TREATMENT, BODY WEIGHT, AND MORTALITY RATE IN ALL GROUPS OF ANIMALS 
No. of 
Hamsters 
GROUP (initial) 
I. 1-2 
II. 12 
III. 12 
IV. 12 
V. 12 
No. of 
Hamsters 
( final) 
12 
12 
9 
11 
9 
Mortality 
Rate 
% 
0 
0 
25 
8.3 
25 
Average 
Initial 
Body Wt. 
in Gms. 
125.7 
132 
129.5 
133.6 
126.6 
Average 
Final 
Body Wt. 
in Gms. 
126.4 
133 
105.5 
140.1 
103.2 
TREATMENT 
Mineral oil 
(triweekly) 
DMBA painting 
(triweekly) 
DMBA & cortisone 
I .M. ( triweekly) 
DMBA & topical 
cortisone (tri-
weekly) 
DMBA & local 
cortisone injec-
tion (triweekly) 
• 
~ 
'° 
J 
Table 3: Time of Appearance in Weeks and Percentage of Various 
Clinical Findings During the Experimental Period. 
TIME IN WEEKS GROUP I GROUP II 
ERY. ULC. TUM. ERY. ULC. 
1 0 0 0 0 0 
2 0 0 0 50 0 
3 0 0 0 100 0 
4 0 0 0 100 41 
5 0 0 0 100 100 
6 0 0 0 100 100 
7 0 0 0 100 100 
8 0 0 0 100 100 
9 0 0 0 100 100 
10 0 0 0 100 100 
•ll 0 0 0 100 100 
12 0 0 0 100 100 
13 0 0 0 100 100 
14 0 0 0 100 100 
15 0 0 0 100 100 
16 0 0 0 100 100 
LEGEND: ERY.= Erythema, ULC.= Ulceration, TUM.= Tumor. 
GROUP III 
TUM. ERY. ULC. 
0 0 0 
0 0 0 
0 50 0 
0 75 0 
8.4 100 44 
25 100 80 
41 100 100 
50 100 100 
83.3 100 90 
83.3 100 90 
100 100 60 
100 100 50 
100 100 50 
100 100 56.5 
100 100 55.5 
100 100 55.5 
51 
GROUP IV GROUP V 
TUM. ER.Y. ULC. TUM. ERY. ULC. TUM. 
0 0 0 0 0 0 0 
0 0 0 0 0 0 0 
0 25 0 0 0 0 0 
0 54.5 0 0 0 0 0 
0 54.5 0 0 50 0 0 
0 72.7 27.2 0 100 0 0 
0 81.8 54.4 0 100 33.3 0 
20 100 100 27.2 100 100 0 
40 56.5 54.5 36.3 100 100 0 
50 81~8 81.8 72.7 100 83.3 8.4 
80 100 100 83.3 100 83.3 41.6 
90 100 100 100 100 100 41.6 
90 100 100 100 100 90 72.7 
100 100 100 100 100 81.8 100 
100 100 100 100 100 50 100 
100 100 100 100 100 33.3 100 •, 
TABLE 4: CCMPARISON OF TUMOR INCIDENCE IN EACH GROUP ACCORDING TO SIZE OF GR<7.ITH 
AT THE END OF THE EXPERIMENTAL PERIOD. 
Leuko-
GROUP .,elakia 
I. 0 
rr. 100% 
111. 100% 
IV. 100% 
V. 100% 
• 
Nodules 
Papilloma 
( .5-1 nm) 
0 
0 
0 
0 
0 
Grade I 
Papilloma 
(2-4 nm) 
0 
41.6% 
75% 
90.9% 
75% 
Grade II 
Papilloma 
(5-7 nm) 
0 
25% 
25% 
9.1% 
12.5% 
Grade III 
Papilloma 
(8-11 nm) 
0 
33.3% 
0 
0 
12.5% 
Malig-
nanc~ 
0 
100% 
55.6% 
100% 
66.7% 
TABLE 5: THE NUMBER AND PERCENTAGE OF ANIMALS IN EACH GROUP WITH BENIGN OR MALIGNANT 
TUMORS AND THE AVERAGE NUMBER OF TUMOR NODULES PER ANIMAL. 
Original 
no. of No. of 
GROUP animals survivors 
I. 12 12 
II. 12 12 
III. 12 9 
IV. 12 11 
v. 12 9 
No. with 
benign No. with 
% tumors % carcinoma 
100 0 0 0 
100 1 8.33 11 
75 4 44.4 5 
91.6 1 9.1 10 
75 3 33.3 6 
Average 
no. of tumor 
% nodules 
0 0 
91.66 5.66 
55.5 4.68 
90.9 5.0 
66.66 3.55 
54 55 
TABLE 6: PERCENTAGE OF INCIDENCE OF VARIOUS HISTOLOGICAL 
CHARACTERISTICS AND DIFFERENT GRADES OF CARCIN-
OMA IN EACH GROUP AFTER SIXTEEN WEEKS OF TREAT-
MENT. 
EXPERIMENTAL GROUPS 
GROUP I GROUP II 
Necrosis 0% 100% 
Parabasilar 0 100 
hyperplasia 
Dyskeratosis 0 100 
Benign tumor 0 0 
Carcinoma 0 8.33 
in-situ 
Total of . 0 8.33 
benign tumors+ 
carcinoma in-situ 
Epidermoid 
carcinoma 
GRADE I. 0 8.33 
II. 0 75 
III. 0 8.33 
Total 0 91.66 
GROUP III GROUP IV GROUP V 
55.5 54.5 66.6 
100 100 100 
66.6 100 100 
33.3 0 11.1 
11.1 9.1 22.2 
44.4 9.1 33.3 
11.1 0 11.1 
44.4 90.9 33.3 
0 0 22.2 
55.5 90.9 66.6 
Fig. 1.--Photograph of a hamster 
strating dryness and scaliness of the 
of systemic cortisone treatment. 
in Group III demon-
skin after 5 weeks 
Fig. 2.--Photograph of a representative buccal mucosa 
of Group V hamster showing minimal erythema after 5 weeks 
of local cortisone administration and DMBA paintings. 
57 
58 
Fig. 3.--Photograph of the buccal pouch of a Group II 
hamster demonstrating severe inflammatory response at about 
the end of the 3rd week of the experiment. X2.5. 
Fig. 4.--Photograph showing the first neoplasm that 
developed in Group II hamsters after 5 weeks of DMBA treat-
ment. X2.5. 
59 
• 
59 
Fig. 5.--Photograph demonstrating a normal buccal pouch 
of a hamster in Group I. Note the relative length and thick-
ness of this pouch as compared to pouches treated with car-
cinogen. X2.S. 
Fig. 6.--Photograph of a cheek pouch in Group II show-
ing severe inflammation, adhesion, and a developing tumor 
with leukoplakic surface. Note the reduction of the depth 
of the pouch as demonstrated by this photograph. X2.S. 
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Fig. 7.--Photograph demonstrating typical tumor mass 
of a hamster buccal pouch in Gro•tp II after 16 weeks of 
DMBA treatment. X2.S. 
Fig. 8.--Photograph illustrating a typical tumor mass 
of a hamster in Group III after 16 weeks of DMBA and system-
ic I.M. cortisone treatment. Note the minimal amount of 
inflanunation as compared to Group II hamsters. X2.S. 
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Fig. 9.--Photograph showing a characteristic tumor 
growth in Group IV hamster receiving DMBA and topical cor-
tisone triweekly. X2.S. 
Fig. 10.--Photograph demonstrating a characteristic 
tumor growth in Group V hamsters. Note the fibrous ap-
pearance of the pouch with minimal inflanunation in this 
group. X2.S . 
• 
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Fig. 11.--Photograph illustrating a marked reduction 
in the adrenal size in Group III hamsters (left specimen) , 
as compared to a normal adrenal gland in Group I hamster 
(right specimen). X2.5. 
Fig. 12.--Medium-power view of buccal mucosa of a ham-
ster in Group I showing normal cornified squamous epithelium 
and submucosa. (Hem~oxylin and eosin stain. Magnification 
X250) 
67 
67 
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Fig. 13.--Medium-power view of buccal pouch in Group 
.II hamsters painted with DMBA alone disclosing squamous 
cell carcinoma with invasion of connective tissue. (He-
matoxylin and eosin stain. Magnification X250). 
Fig. 14.--High-power view of squamous cell carcinoma 
developed in Group II hamster, demonstrating hyperchroma-
tic, prominent nuclei and numerous mitotic figures. (He-
matoxylin and eosin stain. Magnification X450). 
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Fig. 15.--Hamster subjected to DMBA plus systemic cor-
tisone administration. Section, taken after 16 weeks, shows 
squamous cell carcinoma with numerous epithelial pearl for-
mations. (Hematoxylin and eosin stain. Magnification Xl25). 
Fig. 16.--Hamster subjected to DMBA and systemic cor-
tisone. Section taken after 16 weeks shows parakeratosis, 
acanthosis, and parabasilar hyperplasia. (Hematoxylin and 
eosin stain. Magnification X250). 
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Fig. 17.--Low-power view of a hamster subjected to 
DMBA plus topical cortisone for 16 weeks. Note numerous 
areas of keratin pearl formation with invasion of under-
lying connective tissue. (Hematoxylin and eosin stain. 
Magnification X125). 
Fig. 18.--High-power view of buccal pouch in Group IV 
hamsters, disclosing an epidermoid carcinoma invading the 
connective tissue. (Hematoxylin and eosin stain. Magnifi-
cation X450). 
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Fig. 19.--Low-power view of buccal pouch in hamsters 
subjected to DMBA and local cortisone injections, disclo-
sing a poorly differentiated epidermoid carcinoma with 
invasion into connective tissue. (Hematoxylin and eosin 
stain. Magnification Xl25). 
Fig. 20.--Low-power view of a nodular growth (epithe-
lial hyperplasia and signs of downward growth) produced in 
buccal pouch of a Group V hamster, locally injected with 
cortisone and painted with OM.BA as seen 16 weeks after the 
start of the experiment. (Hematoxylin and eosin stain. 
Magnification Xl25). 
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Fig. 21.--Medium-power view of a section of a hamster's 
liver lobule, showing central vein, portal space and hepatic 
cells. (Hematoxylin and eosin stain. Magnification X250). 
Fig. 22.--Medium-power view of a representative section 
of a hamster's pancreas, demonstrating normal islet of Lang-
erhans, as well as acini and intralobular ducts. (Hematoxyl-
in and eosin stain. Magnification X250). 
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Fig. 23.--Medium-power view of a representative trans-
verse section of renal lobules near medulla, showing glom-
erulus, convoluted tubules, and renal corpuscle. (Hematox-
ylin and eosin stain. Magnification X250). 
Fig. 24.--Medium-power view of a section of hamster's 
spleen demonstrating a central artery, numerous lymphocytes, 
and erythrocytes, and a trabecula. (Hematoxylin and eosin 
stain. Magnification X250). 
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Fig. 25.--Medium-power view of a representative section 
of hamster submandibular lymph node, demonstrating a germ-
inal center with various stages of lymphocytic maturation. 
(Hematoxylin and eosin stain. Magnification X250). 
Fig. 26.--Low-power view of a normal cross section of 
hamster's adrenal gland demonstrating medulla, the three 
cortical zone .s, and the capsule. (Hematoxylin and eosin 
stain. Magnification Xl25). 
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Fig. 27.--Low-power view of a cross section of hamster's 
adrenal gland in Group III showing marked atrophy of the 
gland as compared to a normal adrenal gland. (Hematoxylin 
and eosin stain. Magnification Xl25). 
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SUMMARY 
The comparative effects of topical applications, local and sys-
temic injections of cortisone on induction of buccal pouch carcin-
ogenesis by 7,12-Dimethylbenz(a)anthracene have been examined. 
According to the method and condition of this study, hamster 
pouches that were painted with DMBA and received systemic cortisone 
treatment (Group III), when examined clinically, developed relative-
ly smaller epithelial tumors. Furthermore, this group histological-
ly demonstrated only 55.5% malignancy as compared to 91.66 % in Group 
II. Although all pouches painted with DMBA developed lOQ°~ tumors by 
termination of study, pouches receiving local cortisone injection 
(Group V), developed tumor later than the other groups. It was of 
interest to note that only animals that developed infection during 
experimental period, displayed infiltrating tumors histologically. 
Pouches receiving topical cortisone and triweekly DMBA (Group 
IV), displayed no significant difference in incidence of malignancy, 
although they presented with a milder inflannnatory reaction through-
out the period of experimentation, when compared with the group re-
ceiving DMBA alone (Group II). 
The rate of mortality was greatest in groups receiving systemic 
and local injections of cortisone (25%). This could be attributed 
to toxicity of cortisone in high doses. 
There was no evidence of the organ metastasis grossly at the 
time of biopsy, or upon histological evaluation, but definite indi-
cation of moderate amount of adrenal atrophy was noted in groups 
receiving systemic and local cortisone injections. 
